Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAmino acid injections for weight loss are sold by private clinics and online retailers across the UK, often pitched alongside vitamins and lipotropic compounds. The honest answer is that no amino acid injection is licensed by the MHRA as a weight-loss medicine, and there is no robust clinical evidence that they produce meaningful fat loss in adults with obesity. If you are weighing up your options, that distinction matters before you book anything. The medicines that do carry a UK licence for weight management are the GLP-1 and dual GIP/GLP-1 receptor agonists — prescription-only treatments that require a full clinical assessment before a prescriber can lawfully provide them.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The products sold under names like "lipotropic injections", "MIC shots" or "fat-burning amino acids" typically combine compounds such as methionine, inositol, choline and sometimes B12 or B6. The logic offered is that these nutrients support liver metabolism of fat, so injecting them ought to accelerate fat loss. It is a plausible-sounding chain of reasoning. The problem is that plausibility is not evidence, and the evidence that has been gathered does not bear the theory out.
Neither the NHS nor NICE has published guidance recommending any amino acid injection for weight management, because no product in this category has cleared the evidentiary bar set for licensed medicines. The MHRA licenses a treatment when there is controlled trial data showing it works and that its risks are characterised, and if you want to understand the specific claims made about amino acids injections for weight loss, it is worth reviewing what those products actually promise against what the trials show. For a fuller picture of what licensed injectable treatments look like, the NHS England page on weight-management injections is worth reading before you compare anything else.
One common misconception is that because amino acids are "natural" they must be safe and effective. Natural compounds, including many that are found in food, can still be harmful at injection doses, and "natural" carries no weight in pharmacology when it comes to fat loss. A clinic offering these injections without a prescriber-led assessment and a formal treatment plan is offering a product, not clinical care.
If what you are really looking for is an effective injectable treatment for weight management, the decision you face is not "which amino acid blend" but whether a licensed GLP-1 medicine is appropriate for you. Mounjaro (tirzepatide) and Wegovy (semaglutide) are both MHRA-licensed, prescription-only injections with substantial trial evidence behind them. Tirzepatide, for instance, produced an average body-weight reduction of around 20–21% over 72 weeks in the SURMOUNT-1 trial, published in the New England Journal of Medicine, results in a different category from anything seen with lipotropic compounds. You can read more about what licensed weight-loss injections involve in practice.
These medicines work on appetite and satiety signalling, slowing gastric emptying and reducing hunger between meals. The effect is biological and measurable. They are also not suitable for everyone: eligibility rests on BMI, the presence of weight-related health conditions, and a full review of your medical history. A private prescription from a GPhC-registered pharmacy is the lawful route outside the NHS, and that means a real clinical assessment, not a checkbox form. If you are curious about what that process looks like in terms of cost, the weight-loss treatment overview sets out what is typically included in a transparent private price.
Any injection carries risks that a tablet or capsule does not. With unlicensed amino acid products, those risks include contamination, incorrect dosing, and the absence of any post-market pharmacovigilance to catch problems as they emerge. There is no regulatory body tracking adverse events from MIC injections the way the MHRA tracks Yellow Card reports for licensed medicines. Providers sometimes market individual components separately, so understanding what the M injection for weight loss involves, for instance, can help you see how these products are packaged and sold before you make any decisions.
With licensed GLP-1 medicines, the risk profile is well characterised. Side effects are predominantly gastrointestinal (nausea, loose stools, reduced appetite in a way that can occasionally feel unpleasant) and they are most noticeable in the first weeks of treatment or after a dose increase. They settle for most people. Rare but serious effects, including pancreatitis, are flagged clearly in the prescribing information and monitored through ongoing pharmacovigilance. The same scrutiny does not apply to compounds like B6, and reading about what B6 injections for weight loss actually involve makes clear how differently these sit outside the licensed medicines framework. The MHRA's Yellow Card scheme exists precisely so that patients and clinicians can report anything unexpected. That infrastructure does not exist for unlicensed injectables sold outside the regulatory framework.
Before booking any injectable weight-loss product, check whether the provider is a pharmacy registered on the GPhC register. A legitimate service will always require a clinical assessment and will never offer a prescription-only medicine without one. For practical guidance on what to look for when considering buying weight-loss injections from an online provider, there are specific questions worth asking about licensing, prescriber oversight and supply chain.
The decision this keyword ultimately asks about is whether amino acid injections are worth trying. Based on the available evidence and the UK regulatory position, they are not a substitute for a licensed treatment, and there is no shortcut past clinical assessment for the medicines that do work. If you are trying to understand your eligibility for a licensed injectable, what weight you need to be for weight-loss injections explains the BMI and comorbidity thresholds that apply.
At nume, every consultation is read by a GPhC-registered Independent Prescriber on the same day, a real clinician, not automated triage. Our prescribers can tell you clearly whether a licensed injectable is appropriate for your circumstances, and if it is, treatment can be dispatched the same day (orders received before 12pm, Monday to Friday) for free next-working-day delivery. You can read more about the team behind the service on our clinical team page. If you have questions before starting, our FAQs cover the most common ones. When you are ready, start your free consultation and get a straight answer from a prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.